Genetic polymorphism of cytochrome P₄₅₀ 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

By Lee Ai-Young   Kim Min-Jung   Chey Won-Young   Choi Jun   Kim Byung-Gun  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 155-159

Springer Publishing Company

Access to resources Recommend Favorite

Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity: A Case-Control Study in the Netherlands

By Wijnen Petal A.H.M   Drent Marjolein   Nelemans Patty J.   Kuijpers Petra M.J.C.   Koek Ger H.   Neef Cees   Haenen Guido R.M.M.   Bekers Otto  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1125-1134

Adis International

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

By Ingelman-Sundberg Magnus  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 89-104

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to a Geriatric Unit: A Prospective Study of 1756 Patients

By Franceschi Marilisa   Scarcelli Carlo  

Drug Safety, Vol. 31, Iss. 6, 2008-01 ,pp. : 545-556

Adis International

Access to resources Recommend Favorite